Matches any text strings used to describe a molecule.
Systematic Name, Synonym, Trade Name, Registry Number, SMILES, InChI or CSID

Systematic names 1,2-dihydroxybenzene
Synonyms AIBN
Trade names Aspirin
Registry numbers 7732-18-5
SMILES O=C(OCC)C
InChl InChI=1/CH4/h1H4
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 49 results

Search term: C33H35FN2O5 (Found by molecular formula)
123
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
54810


2 of 2 defined stereocentres - 2/2 defined
InChI=1/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1
C33H35FN2O5558.6398131202413527
2163

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)
C33H35FN2O5558.639838208100
56684

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m0/s1
C33H35FN2O5558.6398324000
32701391

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27+/m1/s1
C33H35FN2O5558.6398135800
24837827

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27+/m0/s1
C33H35FN2O5558.63985600
9505362

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C33H35FN2O5/c1-21(2)36-28(18-17-26(37)19-27(38)20-29(39)40)30(23-13-15-24(34)16-14-23)31(22-9-5-3-6-10-22)32(36)33(41)35-25-11-7-4-8-12-25/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1
C33H35FN2O5558.63985400
3262073
InChI=1/C33H35FN2O5/c1-24(2)16-17-35(32(38)23-40-21-26-8-4-3-5-9-26)20-31(37)36(18-25-12-14-28(34)15-13-25)19-27-22-41-30-11-7-6-10-29(30)33(27)39/h3-15,22,24H,16-21,23H2,1-2H3
C33H35FN2O5558.63984300
19778212

1 of 2 defined stereocentres - 1/2 defined
InChI=1/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26?,27-/m1/s1
C33H35FN2O5558.63983200
22582299
InChI=1/C33H35FN2O5/c1-3-5-19-40-28-16-12-25(13-17-28)33(39)35(18-4-2)22-31(37)36(20-24-10-14-27(34)15-11-24)21-26-23-41-30-9-7-6-8-29(30)32(26)38/h6-17,23H,3-5,18-22H2,1-2H3
C33H35FN2O5558.63983200
34219808

1 of 1 defined stereocentres - 1/1 defined
InChI=1/C33H35FN2O5/c1-17-27(22-11-13-26-21(15-22)9-8-14-39-26)29(31(32(37)38)40-33(5,6)7)18(2)35-30(17)24-12-10-23(16-25(24)34)28-19(3)36-41-20(28)4/h10-13,15-16,31H,8-9,14H2,1-7H3,(H,37,38)/t31-/m0/s1
C33H35FN2O5558.63982200
3565303
InChI=1/C33H35FN2O5/c1-33(2,3)26-13-11-24(12-14-26)32(39)35(17-18-40-4)21-30(37)36(19-23-9-15-27(34)16-10-23)20-25-22-41-29-8-6-5-7-28(29)31(25)38/h5-16,22H,17-21H2,1-4H3
C33H35FN2O5558.6398031999982100
4375256
InChI=1/C33H35FN2O5/c1-3-4-7-24-10-14-26(15-11-24)33(39)35(18-19-40-2)22-31(37)36(20-25-12-16-28(34)17-13-25)21-27-23-41-30-9-6-5-8-29(30)32(27)38/h5-6,8-17,23H,3-4,7,18-22H2,1-2H3
C33H35FN2O5558.6398031999982100
8341917

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C33H35FN2O5/c1-4-40-30(33(38)39)20-23-10-16-27(17-11-23)41-19-18-36-29(24-12-14-25(34)15-13-24)21-28(31(36)22(2)3)32(37)35-26-8-6-5-7-9-26/h5-17,21-22,30H,4,18-20H2,1-3H3,(H,35,37)(H,38,39)
C33H35FN2O5558.63982100
9332329

1 of 2 defined stereocentres - 1/2 defined
InChI=1/C33H35FN2O5/c1-21(2)36-28(18-17-26(37)19-27(38)20-29(39)40)30(23-13-15-24(34)16-14-23)31(22-9-5-3-6-10-22)32(36)33(41)35-25-11-7-4-8-12-25/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26?,27-/m1/s1
C33H35FN2O5558.63982100
416543

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C33H35FN2O5/c1-33(2,3)41-31(38)29-17-10-18-36(29)30(37)28(19-21-11-4-9-16-27(21)34)35-32(39)40-20-26-24-14-7-5-12-22(24)23-13-6-8-15-25(23)26/h4-9,11-16,26,28-29H,10,17-20H2,1-3H3,(H,35,39)/t28-,29-/m0/s1
C33H35FN2O5558.63982200
416544

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C33H35FN2O5/c1-33(2,3)41-31(38)29-16-9-17-36(29)30(37)28(19-21-10-8-11-22(34)18-21)35-32(39)40-20-27-25-14-6-4-12-23(25)24-13-5-7-15-26(24)27/h4-8,10-15,18,27-29H,9,16-17,19-20H2,1-3H3,(H,35,39)/t28-,29-/m0/s1
C33H35FN2O5558.63982200
416545

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C33H35FN2O5/c1-33(2,3)41-31(38)29-13-8-18-36(29)30(37)28(19-21-14-16-22(34)17-15-21)35-32(39)40-20-27-25-11-6-4-9-23(25)24-10-5-7-12-26(24)27/h4-7,9-12,14-17,27-29H,8,13,18-20H2,1-3H3,(H,35,39)/t28-,29-/m0/s1
C33H35FN2O5558.63982200
418406

2 of 3 defined stereocentres - 2/3 defined
InChI=1/C33H35FN2O5/c1-33(2,3)41-31(38)27-18-11-19-36(27)30(37)29(28(34)21-12-5-4-6-13-21)35-32(39)40-20-26-24-16-9-7-14-22(24)23-15-8-10-17-25(23)26/h4-10,12-17,26-29H,11,18-20H2,1-3H3,(H,35,39)/t27-,28?,29-/m0/s1
C33H35FN2O5558.63982200
3119281
InChI=1/C33H35FN2O5/c1-23(2)16-17-35(31(37)18-24-10-14-28(40-3)15-11-24)21-32(38)36(19-25-8-12-27(34)13-9-25)20-26-22-41-30-7-5-4-6-29(30)33(26)39/h4-15,22-23H,16-21H2,1-3H3
C33H35FN2O5558.63982100
122267055

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H35FN2O5/c1-23(37)41-27-18-16-25(17-19-27)21-30(35-32(39)28-13-5-6-14-29(28)34)33(40)36-20-8-12-26(22-36)31(38)15-7-11-24-9-3-2-4-10-24/h2-6,9-10,13-14,16-19,26,30H,7-8,11-12,15,20-22H2,1H3,(H,35,39)
C33H35FN2O5558.63981100
123

Advertisement